Active Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)
CSF2; GMCSF; Sargramostim; Molgramostin; Granulocyte-Macrophage Colony Stimulating Factor
- Product No.APA045Hu61
 - Organism SpeciesHomo sapiens (Human) Same name, Different species.
 - Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
 - Traits Freeze-dried powder
 - Purity> 95%
 - Isoelectric Point5.2
 - ApplicationsCell culture; Activity Assays.
 - DownloadInstruction Manual
 - UOM 10µg50µg 200µg 1mg 5mg
 - FOB
    
                                    US$ 216 
            
                
                        US$ 540 
                                        US$ 1080 
                                        US$ 3240 
                                        US$ 8100 
                            
For more details, please contact local distributors! 
ACTIVITY TEST
                                TF-1, the human erythroleukemia cell line,provides a good system for detecting the activity of GM-CSF for it is a cell line of immature erythroid origin that completely depends on interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF) for long term growth. As reported, GM-CSF was also able to induce differentiation of human monoblastic leukemia cell line U937. In house data was obtained by the following experiment: TF-1 cells and U937 cells were incubated in the presence of various concentrations of rhGM-CSF, then cells were observed by inverted microscope everyday . <br/>Cell proliferation of TF1 cells after incubation with GM-CSF (10ng/mL) for 3 days was shown in Figure 1.The ED50 is 0.74ng/ml.
                                Cell differentiation of U937 cells after incubation with GM-CSF (10ng/mL) for 5 days was shown in Figure 2.
USAGE
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- 
                    
                        BCA Protein Quantification Kit
                                     - 
                    
                        Molecular Mass Marker for Protein
                                     - 
                    
                        Monoclonal Antibody Customized Service
                                     - 
                    
                        Polyclonal Antibody Customized Service
                                     - 
                    
                        Protein Activity Test Experiment Service
                                     - 
                    
                        Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
                                     - 
                    
                        Buffer
                                     - 
                    
                        Lentivirus Packaging Experiment Service
                                     - 
                    
                        Adenovirus Packaging Experiment Service
                                     - 
                    
                        Real Time PCR Experimental Service
                                     - 
                    
                        Spike RBD Protein (S-RBD)
                                     - 
                    
                        Protein G
                                     - 
                    
                        Protein A
                                     
| Magazine | Citations | 
| Journal of Toxicology and Environmental Health | Effects of 900-MHz Microwave Radiation on γ-Ray-Induced Damage to Mouse Hematopoietic System PubMed: 20391130 | 
| 5 | Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial Pubmed:24525316 | 
| Archives of Virology | Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in central China Pubmed:29305646 | 
| BioMed Research International | Activated Macrophages of Monocytic Origin Predominantly Express Proinflammatory Cytokine Genes, Whereas Kupffer Cells Predominantly Express Anti … | 
| bulletin of experimental biology and medicine | Quantitative and Qualitative Characterization of Phagocytic Activity of Macrophages of Bone Marrow and Fetal Origin Pubmed: 31183654 | 
| Exp Mol Pathol | The regulatory role of SFRP5/WNT5A axis in allergic rhinitis through inhibiting JNK pathway activation and lowering mucin generation in human nasal?¡ 33285209 | 
| Vaccine | Co-delivery of PSMA antigen epitope and mGM-CSF with a cholera toxin-like chimeric protein suppressed prostate tumor growth via activating dendritic cells and?¡ 33612342 | 
        
                            
                                
